FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1999923343> ?p ?o ?g. }

• W1999923343 endingPage "336" @default.
• W1999923343 startingPage "328" @default.
• W1999923343 abstract "Abstract: Background: The dynamic pattern of the cellular infiltration and mRNA expression of chemokines in rat‐to‐mouse skin xenografts were examined to gain an understanding of the possible role of chemokines in the stronger cellular immune responses to xenografts compared with the allo‐response. Methods: The mean survival time of the xenografts was approximately 2 days less than that of allografts (10.7 ± 0.9 days vs. 8.9 ± 0.7 days, P < 0.05). In comparison with the allografts, the xenografts were characterized by a very early infiltration of monocytes/macrophages (day 3) and a larger number of CD4 + and CD8 + cells, as well as neutrophil infiltration in the early phase (day 5), and larger number of CD8 + and CD11b + cells, as well as macrophage infiltration, in the later phase (day 7). Xenografts showed stronger interferon (IFN)‐inducible 10‐kDa protein (IP‐10) and monokine induced by IFN (MIG) mRNA expression levels, which appeared earlier than in the allografts. In the later phase, strong expression of regulated on activation, normal T cell expressed and secreted was observed. Cytokine mRNA expression in the xenografts could be summarized by higher expression of IFN‐ γ , interleukin (IL)1 β , IL6, and transforming growth factor ‐ β 1 mRNA than in the allografts. These results suggest that the early increased CXC‐chemokine expression, such as IP‐10 and MIG, which has been known to be mainly produced by macrophages, may play a critical role in the stronger cellular xenograft rejection compared with allograft rejection. Therefore, MIG antiserum or CXCR3 antiserum was administered to the rat skin‐engrafted mice every other day until rejection. Results: Compared with the control normal rabbit serum‐treated mice, either the MIG antiserum‐ or CXCR3 antiserum‐treated mice showed a delayed rejection of approximately 2 days (8.3 ± 0.5 days vs. 10.6 ± 0.5 days or 10.8 ± 1.9 days, respectively, P < 0.05). Conclusion: Overall, these results suggest that the more aggressive rejection of xenografts compared with allografts is due to the earlier expression of CXC‐chemokines, IP‐10 and MIG, and subsequent adjuvant effects of proinflammatory cytokines." @default.
• W1999923343 created "2016-06-24" @default.
• W1999923343 creator A5001042760 @default.
• W1999923343 creator A5006883605 @default.
• W1999923343 creator A5010889338 @default.
• W1999923343 creator A5011960125 @default.
• W1999923343 creator A5023097709 @default.
• W1999923343 creator A5045587524 @default.
• W1999923343 creator A5052064676 @default.
• W1999923343 creator A5060181991 @default.
• W1999923343 creator A5066672164 @default.
• W1999923343 date "2006-06-09" @default.
• W1999923343 modified "2023-10-11" @default.
• W1999923343 title "Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts" @default.
• W1999923343 cites W1558253890 @default.
• W1999923343 cites W1584518580 @default.
• W1999923343 cites W1602835962 @default.
• W1999923343 cites W1629501654 @default.
• W1999923343 cites W1964289208 @default.
• W1999923343 cites W1984123968 @default.
• W1999923343 cites W1989025715 @default.
• W1999923343 cites W1989642841 @default.
• W1999923343 cites W1993323374 @default.
• W1999923343 cites W1997491414 @default.
• W1999923343 cites W2019513091 @default.
• W1999923343 cites W2027344845 @default.
• W1999923343 cites W2045134465 @default.
• W1999923343 cites W2054128589 @default.
• W1999923343 cites W2058776595 @default.
• W1999923343 cites W2063920217 @default.
• W1999923343 cites W2064835686 @default.
• W1999923343 cites W2080047968 @default.
• W1999923343 cites W2115289037 @default.
• W1999923343 cites W2168263358 @default.
• W1999923343 cites W2176220887 @default.
• W1999923343 cites W4251829470 @default.
• W1999923343 doi "https://doi.org/10.1111/j.1399-3089.2006.00311.x" @default.
• W1999923343 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16768726" @default.
• W1999923343 hasPublicationYear "2006" @default.
• W1999923343 type Work @default.
• W1999923343 sameAs 1999923343 @default.
• W1999923343 citedByCount "9" @default.
• W1999923343 countsByYear W19999233432012 @default.
• W1999923343 countsByYear W19999233432013 @default.
• W1999923343 countsByYear W19999233432018 @default.
• W1999923343 crossrefType "journal-article" @default.
• W1999923343 hasAuthorship W1999923343A5001042760 @default.
• W1999923343 hasAuthorship W1999923343A5006883605 @default.
• W1999923343 hasAuthorship W1999923343A5010889338 @default.
• W1999923343 hasAuthorship W1999923343A5011960125 @default.
• W1999923343 hasAuthorship W1999923343A5023097709 @default.
• W1999923343 hasAuthorship W1999923343A5045587524 @default.
• W1999923343 hasAuthorship W1999923343A5052064676 @default.
• W1999923343 hasAuthorship W1999923343A5060181991 @default.
• W1999923343 hasAuthorship W1999923343A5066672164 @default.
• W1999923343 hasConcept C121332964 @default.
• W1999923343 hasConcept C12823836 @default.
• W1999923343 hasConcept C13373296 @default.
• W1999923343 hasConcept C153400128 @default.
• W1999923343 hasConcept C167672396 @default.
• W1999923343 hasConcept C17502307 @default.
• W1999923343 hasConcept C179661763 @default.
• W1999923343 hasConcept C203014093 @default.
• W1999923343 hasConcept C25532541 @default.
• W1999923343 hasConcept C2778690821 @default.
• W1999923343 hasConcept C2779603739 @default.
• W1999923343 hasConcept C5858377 @default.
• W1999923343 hasConcept C83360876 @default.
• W1999923343 hasConcept C86803240 @default.
• W1999923343 hasConcept C8891405 @default.
• W1999923343 hasConcept C97355855 @default.
• W1999923343 hasConceptScore W1999923343C121332964 @default.
• W1999923343 hasConceptScore W1999923343C12823836 @default.
• W1999923343 hasConceptScore W1999923343C13373296 @default.
• W1999923343 hasConceptScore W1999923343C153400128 @default.
• W1999923343 hasConceptScore W1999923343C167672396 @default.
• W1999923343 hasConceptScore W1999923343C17502307 @default.
• W1999923343 hasConceptScore W1999923343C179661763 @default.
• W1999923343 hasConceptScore W1999923343C203014093 @default.
• W1999923343 hasConceptScore W1999923343C25532541 @default.
• W1999923343 hasConceptScore W1999923343C2778690821 @default.
• W1999923343 hasConceptScore W1999923343C2779603739 @default.
• W1999923343 hasConceptScore W1999923343C5858377 @default.
• W1999923343 hasConceptScore W1999923343C83360876 @default.
• W1999923343 hasConceptScore W1999923343C86803240 @default.
• W1999923343 hasConceptScore W1999923343C8891405 @default.
• W1999923343 hasConceptScore W1999923343C97355855 @default.
• W1999923343 hasIssue "4" @default.
• W1999923343 hasLocation W19999233431 @default.
• W1999923343 hasLocation W19999233432 @default.
• W1999923343 hasOpenAccess W1999923343 @default.
• W1999923343 hasPrimaryLocation W19999233431 @default.
• W1999923343 hasRelatedWork W135183594 @default.
• W1999923343 hasRelatedWork W1989677994 @default.
• W1999923343 hasRelatedWork W2043945734 @default.
• W1999923343 hasRelatedWork W2063323386 @default.
• W1999923343 hasRelatedWork W2094231393 @default.
• W1999923343 hasRelatedWork W2144430251 @default.

• next